Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Tomaszow Mazowiecki

32 clinical trials in Tomaszow Mazowiecki, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Tomaszow Mazowiecki at a glance
32
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

32 trials in Tomaszow Mazowiecki

Open in trial search

Study on Metformin's Effect in Reducing Unplanned Heart Procedures in Non-Diabetic Patients with Acute Coronary Syndrome

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Metformin Hydrochloride
  • Sponsor:Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy

Safety and Tolerability of Alisertib Sodium and Paclitaxel in Patients with Small Cell Lung Cancer (Phase 2 Study)

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Alisertib Sodium
  • Sponsor:Puma Biotechnology Inc.

A study of PF-08634404 and a drug combination in adults with advanced or metastatic non-small cell lung cancer

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Pfizer Inc.

A study testing BNT326 and BNT327 with drug combination for safety and effectiveness in people with advanced non-small cell lung cancer

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:BNT326
  • Sponsor:BioNTech SE

A Study of Telisotuzumab Adizutecan Compared to Standard Treatment in Adults with Advanced Non-Small Cell Lung Cancer After Previous Treatment

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Amivantamab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

A Study Comparing PF-08046054 to Docetaxel in Adults with Previously Treated PD-L1 Positive Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Pfizer Inc.

A Study Testing Casdatifan and Cabozantinib Compared to Placebo and Cabozantinib in Patients With Advanced Clear Cell Kidney Cancer

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:AB521
  • Sponsor:Arcus Biosciences Inc.

Study of trastuzumab deruxtecan with pembrolizumab versus platinum chemotherapy with pembrolizumab for patients with untreated HER2-positive non-small cell lung cancer

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Daiichi Sankyo Inc.

Study Comparing Rilvegostomig with Fluoropyrimidine and Trastuzumab Deruxtecan to Standard Treatment for Patients with HER2-positive Gastric Cancer

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:AstraZeneca AB

Study on the Effectiveness and Safety of Belinostat and Pralatrexate with Drug Combination for Newly Diagnosed Peripheral T-Cell Lymphoma Patients

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Belinostat
  • Sponsor:Acrotech Biopharma Inc.

Study on Ifinatamab Deruxtecan and Topotecan for Patients with Relapsed Small Cell Lung Cancer

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Topotecan
  • Sponsor:Daiichi Sankyo Inc.

Seasonal allergy

Not yet recruiting

Study on the Effectiveness of Beltavac with Grass Pollen Extract for Patients with Allergic Rhinoconjunctivitis and Possible Asthma

Registered drug
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Placebo
  • Sponsor:Probelte Pharma S.L.

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Tomaszow Mazowiecki

What the registry says about research in the country

01 Oncology - Lung Cancer

Groundbreaking research focusing on small-cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), evaluating novel therapeutic approaches and combination treatments.

  • Advanced stage lung cancer treatments
  • Immunotherapy combinations
  • Novel therapeutic agents

Multiple trials investigating durvalumab and other innovative compounds for improved patient outcomes.

02 Breast Cancer Research

Comprehensive studies targeting various types of breast cancer, including hormone receptor-positive, HER2-negative, and triple-negative variants.

  • Metastatic breast cancer treatments
  • Targeted therapies
  • Pre- and post-surgical interventions

Innovative approaches combining immunotherapy with targeted treatments for enhanced efficacy.

03 Gastrointestinal Oncology

Studies examining treatments for gastric cancer and colorectal cancer, with emphasis on targeted therapies and novel drug combinations.

  • Advanced gastric cancer treatments
  • Metastatic colorectal cancer therapies
  • HER2-targeted approaches

Focus on personalized treatment strategies based on specific biomarkers.

04 Immunology and Allergies

Research into allergic conditions and immunotherapy treatments, including studies on rhinoconjunctivitis and dust mite allergies.

  • Allergen-specific immunotherapy
  • Respiratory allergy treatments
  • Novel therapeutic approaches

Evaluation of innovative immunotherapy protocols for improved patient care.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.